<DOC>
	<DOCNO>NCT01448954</DOCNO>
	<brief_summary>This study examine safety , tolerability , pharmacokinetics functional activity ADC3680B administer daily 28 day subject partly control atopic asthma .</brief_summary>
	<brief_title>A Study Evaluate Safety , Tolerability Pharmacokinetics ADC3680B Subjects With Partly Controlled Atopic Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Partially control mildmoderate atopic asthma Receiving inhaled corticosteroid Nonsmoker former smoker Males females age 18 55 year inclusive If female , must nonchildbearing potential History acute severe asthma attack History COPD Other serious respiratory medical condition may interfere outcome study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>